Metformin may inhibit activation of the nuclear factor kappa B, inhibit tumor growth, induce apoptosis in esophageal cancer cell lines, and inhibit cell motility by inducing E-cadherin expression (32). This evidence concerns the gene CDH1 and esophageal cancer.